The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...

The study looked at the potential benefits of cataract surgery in patients with a prior diagnosis of optic neuropathy. Patients with and without optic neuropathies showed significant improvement in ...

"Our decision to treat typically needs to be made on the balance of likelihood, before the diagnosis of an associated disease process can be fully established, with definitive tests for multiple ...

Genetic analysis combined with consideration of other risk factors could significantly improve early distinction between people with optic neuritis who are likely to develop multiple sclerosis (MS), ...

The US Food and Drug Administration has granted breakthrough therapy designation to Oculis’ neuroprotective candidate ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Fampridine resulted in no significant observed ...

A new therapeutic agent tested in a mouse model of multiple sclerosis (MS) produced anti-inflammatory activity and prevented loss of cells in the optic nerve, according to a new study by researchers ...

Erythropoietin (EPO), shown in early studies to potentially provide neuroprotection for patients with optic neuritis, failed to provide any significant neuroprotection in comparison with placebo in a ...

A 34 year-old woman presented with right facial numbness. She had left optic neuritis two years ago. Multiple Sclerosis (MS): Flair axial MRI images at the level of the medulla/cerebellum (left), and ...

Optic neuritis [ON] is generally identified as the most frequent potential risk factor associated with future development of multiple sclerosis [ms]. Whereas coherency in case of the adult disease is ...

Oligoclonal IgG bands (OCB) in the cerebrospinal fluid (CSF) can herald conversion to multiple sclerosis (MS) in children with demyelinating optic neuritis, a new study reveals. In 357 children with ...